Smith Scott Andrew - Insider Stock Trading - OpenInsider

CIK: 1614975 - Address: C/O Bioatla, Inc. 11085 Torreyana Road, San Diego, CA 92121

17 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/5/24 20:01	3/3/24	VTRS	Viatris Inc	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	PA	DO	CEO	M.d	0	0.00	0	141		85	D
12/7/21 17:41	11/30/21	BCAB	Bioatla, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Smith Scott Andrew	CA	DO	P	S.m	-91	22.27	0	-4	-1	346	D
12/6/21 20:42	11/29/21	BCAB	Bioatla, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Smith Scott Andrew	CA	DO	P	S	-10	23.89	0	0	0	350	D
11/30/21 20:06	11/22/21	BCAB	Bioatla, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Smith Scott Andrew	CA	DO	P	S.m	-40	25.26	0	-2	0	350	D
10/7/21 18:09	10/1/21	BCAB	Bioatla, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Smith Scott Andrew	CA	DO	P	S	-90	30.18	0	-3	-1	352	D
8/30/21 21:43	8/26/21	BCAB	Bioatla, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Smith Scott Andrew	CA	DO	P	S	-1,335	40.16	0	-33	-9	355	D
6/28/19 15:25	6/28/19	SBPH	Spring Bank Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	MA	D		P	49	4.09	0	12	637	14	D
2/20/18 17:03	2/17/18	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	0	7	16	52	D
12/20/17 16:05	12/19/17	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	0	3	8	47	D
8/1/17 17:34	7/28/17	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	0	5	12	46	D
12/27/16 16:17	12/23/16	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	33	6	20	39	D	9	-3	25	12	0	2	3	0	-1	1	-5	5
12/6/16 16:05	12/2/16	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	33	4	12	36	D	3	6	9	9	19	-3	-4	-2	-4	-4	1	5
5/3/16 21:28	4/29/16	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	33	10	41	34	D	41	-5	-16	4	4	0	-5	-1	-2	-1	3	11	1
12/18/15 16:22	12/17/15	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	33	5	21	29	D	40	-1	-4	-9	-7	0	0	2	1	11	-2	-8	-10	6
12/7/15 16:16	12/3/15	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	33	10	60	27	D	38	-3	0	-6	-8	3	-2	0	3	-1	7	-6	-1	7
5/4/15 19:16	4/30/15	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	33	7	44	22	D	90	49	5	-7	-14	-5	-4	-3	-2	3	4	19	14	-4
12/2/14 16:14	11/30/14	CELG	Celgene Corp /de/	DE	Health	Drug	Pharmaceutical Preparations	Smith Scott Andrew	NJ	O	See Rema	M.d	0	0.00	33	7		6	D	186	40	46	19	23	5	6	2	-1	3	-3	4	-2	-4

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact